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INHIBITION OF CYTOCHROME P-450 BUT NOT NEUTROPHIL DEPLETION
PREVENTS THE PULMONARY TOXICITY ASSOCIATED W ITH 1NITRONAPHTHALENE
Steven Michael Green, M.S.
Western Michigan University, 1993
1-Nitronaphthalene (1-NN) is an environmental contaminant that has been
shown to cause pulmonary toxicity in rodents.

To examine the contribution o f

cytochrome P-450 to the metabolism and subsequent toxicity o f 1-NN, rats were
pretreated with chloramphenicol, a suicide substrate o f P-450.

To determine if

inflammation plays a role

pretreated

in

1-NN toxicity,

rats were

with

cyclophosphamide to deplete neutrophils. In both experiments, morphological analysis
o f the lower airways was performed with light and electron microscopy. A second
group o f animals was examined for biochemical indicators o f inflammation and cell
damage. The parameters examined were cell content, protein content and lactate
dehydrogenase activity in bronchoalveolar fluid, and tissue myeloperoxidase activity.
The results showed that pretreatment with chloramphenicol prevented the cytotoxicity
associated with 1-NN, but not the inflammatory response.

Pretreatment with

cyclophosphamide did not prevent 1-NN cytotoxicity, but did prevent neutrophildependent aspects o f inflammation.
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STATEMENT OF THE PROBLEM
1-Nitronaphthalene (1-NN) is an environmental contaminant found in diesel
exhaust, cigarette smoke and industrial processes (IARC Monographs). While there is
no data available on human exposure to 1-NN, rodent studies have shown that
exposure causes preferential damage to the distal bronchiolar epithelium (Johnson,
Riley, & Cornish, 1984). Pulmonary damage is postulated to occur due to metabolic
activation o f 1-NN by cytochrome P-450 isozymes, however, attempts to prove this
have produced conflicting results in vivo (Johnson, et al., 1984) and in vitro
(Rasmussen, 1986). The elucidation o f 1-NN metabolism is further complicated by the
presence o f other pulmonary enzymes that are capable o f metabolizing foreign
compounds. These include prostaglandin h synthase (PHS), flavin monooxygenase
(FMO), and epoxide hydrolase.
Additionally, inflammation is a common consequence o f cytotoxic tissue injury.
This response can lead to tissue damage through the oxidative and enzymatic products
o f neutrophil and macrophage activation (Henson & Johnston, 1987). There are no
published results defining the role o f inflammation on the pathogenesis o f 1-NN
induced lesions. This study examines the effect o f cytochrome P-450 inhibition or
neutrophil depletion on the pulmonary toxicity o f 1-NN using morphologic and
biochemical indicators o f damage.

1
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INTRODUCTION
1-Nitronaphthalene
1-Nitronaphthalene is found in diesel exhaust, cigarette smoke and industrial
dyes (IARC Monographs).

There have been several types o f studies done to

determine the metabolic fate o f 1-NN.

Rasmussen (1986) showed that covalent

binding to macromolecules occurs when slices, isolated cells, and microsomes from the
lungs o f mice are incubated with 1-NN. This study further showed that a metabolite
rather than the parent compound was responsible for toxicity using heat-inactivated
incubations, and that the reaction was oxygen dependent. This was proposed to be a
cytochrome P-450 dependent mechanism by the use o f traditional inhibitors such as
SKF 525a and nitrogen gas. These results indicated that 1-NN was metabolized in
vitro to oxidative metabolites by cytochrome P-450.
El-Bayoumy & Hecht (1982) showed that pretreatment o f rat liver supernatant
with Arochlor 1254, a powerful inducer o f group LA. isozymes, prior to treatment with
1-NN caused the production o f oxidative metabolites consisting o f nitronaphthols and
dihydrodiols. Conversely, Johnson & Cornish (1978) showed that 1-naphthylamine, a
reductive product o f 1-NN metabolism was excreted in the urine 24 hours after a 100
mg/kg i.p injection o f 1-NN. Another study by Johnson et al., (1984) showed that
pretreatment o f rats with SKF 525a prevented liver toxicity, but not lung toxicity in
vivo. This conflicts with the in vitro results obtained by Rasmussen (1986) which
show that SKF-525a inhibited the production o f reactive metabolites from 1-NN. The
results o f these experiments indicate that both oxidative and reductive pathways may
contribute to 1-NN metabolism and toxicity, although the studies performed up to
2
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now do not indicate which metabolites are injurious in vivo and in what order they are
produced.
1-Nitronaphthalene has not exhibited carcinogenic activity in either rats or
mice fed oral doses o f 1-NN (National Cancer Institute, 1978). However, positive
results were obtained from the Ames test using error-rprone S. Typhimuriam. Strains
o f bacteria that did not posses nitroreductase activity failed to produce positive results
(McCoy, Rosenkranz, Petrullo, Rosenkranz & Mermelstein, 1981).
The Clara Cell
The Clara cell is the initial site o f 1-NN toxicity after a lOOmg/kg dose
administered intraperitonealy (Sauer, 1991). This cell, originally described by Clara in
1937 is a multi-functional resident o f the distal and terminal airways o f mammals.
Some aspects o f Clara cell function include secretion o f a phospholipid from electrondense granules into the serous lining o f the airways (Stinson & Loosli, 1978),
metabolism o f foreign compounds (Boyd, 1977), and possibly differentiation into other
cell types to replace dead cells (Evans, Cabral-Anderson, & Freeman, 1978).
Histochemical results have shown that the majority o f pulmonary xenobioticmetabolizing enzymes are located within Clara cells (Baron & Voigt, 1990). These
cells are rich in microsomal enzymes such as cytochrome P-450, prostaglandin h
synthase, epoxide hydrolase and flavin monooxygenase; and in cytosolic enzymes such
as UDP-glucoronyltransferase and glutathione-s-transferase (Baron & Voigt, 1990).
This is in contrast to liver which has a relatively homogenous enzyme distribution.
Clara cells and ciliated cells compose the epithelium o f the distal and terminal
bronchioles; compared to the larger airways which are composed mainly o f ciliated
and goblet cells (Breeze & Wheeldon, 1977). This concentration o f P-450 containing
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cells correlates with the lower airways being a common site o f damage due to
cytotoxic drugs requiring activation (Boyd, Statham, & Longo, 1980). This has been
illustrated with several chemicals that are converted to toxic metabolites within the
lung, such as 4-ipomeanol (Boyd, 1976), 3-methylfuran (Boyd, 1978), and carbon
tetrachloride (Boyd, Statham, & Longo, 1980).
Several P-450 isozymes are found in the lung.

One isozyme, O BI, has a

pulmonary concentration that is nearly double the hepatic concentration (de Waziers,
Cugnenc, Yang, Leroux, & Beaune, 1990). This isozyme is expressed primarily in the
Clara cell (Baron & Voigt, 1990). Johnson et al., (1984) reported that pretreatment o f
rats with phenobarbital, a powerful inducer o f hepatic HB1, shifted the focus o f 1-NN
toxicity from the lung to the liver. This lead to the theory that pulmonary IIB1 was
responsible for the first pass metabolism o f 1-NN.
Metabolic Activation and Metabolism
Ideally, when a compound is metabolized, the products become less reactive
and more water soluble; which aids in excretion by the kidneys.

Conversely, a

compound can be metabolically activated, resulting in the metabolites becoming more
reactive then the parent compound (Guengerich & Liebler, 1987). In the case o f toxic
chemicals, activation produces a metabolite that danjages the cell through destruction
or modification o f an essential component. Some examples include lipid peroxidation,
alkylation and crosslinking o f DNA, depletion o f essential cofactors, such as NADPH
and ATP (Nelson & Pearson, 1990), or modification o f proteins to the point where the
structure-function relationship is lost (Nelson & Pearson, 1990). This is o f special
importance in the case o f enzymes and structural proteins such as membrane channels
and receptors.
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As reviewed by Sipes & Gandolfi (1986), two distinct classes o f reactions
(termed phases) have been identified in the metabolism o f endogenous and exogenous
molecules. Phase I reactions are associated with reactions that include oxidation,
reduction, hydroxylation and dealkylation o f the parent compound.

Enzymatic

hydrolysis o f amides or esters and the reduction o f epoxides to fram-dihydrodiols are
also considered to be phase I reactions. Some enzymes that are associated with phase
I are the cytochrome P-450 enzyme family, prostaglandin h synthase, flavin
monooxygenase and epoxide hydrolase.

Phase I enzymes are located in the

microsomal portion o f the cell, while phase I I enzymes (see below) tend to be located
in the cytoplasm.
Prostaglandin h synthase is a bifunctional enzyme with oxygenase and
peroxidative activities (Eling et al., 1990). The oxygenase property, cyclooxygenase,
catalyzes the conversion o f arachidonic acid to the cyclic endoperoxide prostaglandin
G2. The peroxidase property reduces prostaglandin G2 to the corresponding alcohol
prostaglandin H2 (Eling et al., 1990).

Sometimes, this reaction can cause the

concomitant oxidation o f a second, unrelated substrate and is termed cooxidation.
Identical metabolites can be produced from cooxidation by PHS or oxidative
metabolism by P-450 (Eling et al., 1990). Both P-450 and PHS can act upon a wide
variety o f compounds while FMO is usually associated with the N-oxidation o f amines
(Sipes & Gandolfi, 1986).
Phase II reactions cause the addition o f a polar side group to the parent
compound, and are termed conjugation reactions.

Some o f the additives include

glucuronic acid, glutathione, sulfate, and amino acids (Sipes, 1986). These reactions
are catalyzed by specific transferase enzymes with the exception o f glutathione, which
can react with compounds enzymaticaly and non-enzymaticaly (Sipes & Gandolfi,
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1986). Conjugation produces bulkier, polar molecules that are more readily excreted
by the kidneys than the parent compound (Sipes & Gandolfi, 1986). Addition o f these
groups can also increase the molecular weight o f a molecule to the point where it can
be excreted in the bile as well as the urine (Levine, 1978).
Boyd (1980) described three mechanisms o f lung injury by toxic chemicals.
The first consists o f compounds whose metabolites are activated and bind within the
lung. The second consists o f compounds that are activated in the liver but are stable
enough to enter the circulation and travel to the lung; which is the next capillary bed.
Group two metabolites cause damage that results in symptoms similar to Adult
Respiratory Distress Syndrome, which is characterized by endothelial damage and
increased vascular permeability.

The third group consists o f compounds whose

metabolites are not necessarily toxic themselves, but cause activation o f oxygen to a
reactive species with concomitant depletion o f NADPH. This group is illustrated by
paraquat, diquat and nitrofurantoin, which cause damage to endothelium and type I
epithelial cells.
Cytochrome P-450
Cytochrome P-450 is a super-family o f more then 20 heme-containing
isozymes.

P-450 isozymes are ubiquitous throughout the body, with the highest

concentration found in the liver (de Waziers et al., 1990). Other organs such as the
lungs, skin, intestine and kidneys contain significant amounts o f P-450 isozymes;
although constitutive expression differs between hepatic and extrahepatic tissues (de
Waizers et al., 1990). The rat liver contains small amounts o f isozymes IA2, IIB1,
IEE1 and IIC6 with IIC11 being the major constitutively expressed isozyme (de
Waziers et al., 1990). The rat lung contains isozyme IIB1 as its major isozyme with
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smaller amounts o f IA1 and IIIA 2 present (Baron & Voigt, 1990). The amount o f
HB1 expressed in the lung is over 50% greater than the liver and is concentrated in the
bronchiolar Clara cells (Baron & Voigt, 1990).
The cycle o f P-450 action involves transfer o f two reducing equivalents from
NADPH to molecular oxygen by the enzyme NADPH-cytochrome P-450 reductase
(Gungerich & Liebler, 1987). One atom o f oxygen becomes reduced to water while
the other is conjugated to the compound. The exception to this is nitroreduction,
where reducing equivalents are transferred directly to the substrate. This reaction
occurs in hypoxic conditions and is inhibited by oxygen, which competes for the
reducing equivalents (Gungerich & Liebler, 1987).
As reviewed by Murray & Reidy (1990), exposure to xenobiotics can lead to
induction or inhibition o f P-450 isozymes. The specificity o f inducers and inhibitors is
highly variable.

Some w ill interact with select isozymes, while others w ill affect

several. Induction results in the production o f isozymes at a greater rate then normal,
or the production o f an isozyme that is not normally expressed.
There are two types o f cytochrome P-450 inhibitors, reversible and
irreversible. Reversible inhibitors act by forming a complex with the enzyme that later
dissociates.

Examples include SKF 525a, and piperonyl butoxide.

Irreversible

inhibitors-also known as mechanism based inhibitors or suicide substrates-covalently
bind to the enzyme, permanently inactivating it. Some examples o f suicide substrates
are chloramphenicol and 1-aminobenzotriazole.
Neutrophils and Oxidative Stress
Oxidative stress is defined as injury that occurs to tissue by reactive oxygen
species. Neutrophils are the cell most commonly associated with reactive oxygen
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production; although endothelial cells, macrophages and eosinophils also produce
reactive species (Henson & Johnston, 1987). Neutrophils have received most o f the
attention since they are the most common granular leukocyte in the blood, and are the
first cell type to arrive in high numbers after an inflammatory stimulus. Aside from the
production o f reactive oxygen species, neutrophils also possess enzymes that can
damage tissue (Weiss, 1989).
As reviewed by Weiss (1989) the primary oxidative reaction associated with
neutrophils is the myeloperoxidase/hypochlorus acid reaction. Stimulated neutrophils
undergo a respiratory burst that results in activation o f NADPH oxidase; a membrane
bound enzyme that reduces molecular oxygen to superoxide. Hydrogen peroxide is
produced from superoxide by the enzyme superoxide dismutase or the spontaneous
interaction between two superoxide molecules. The copious amounts o f hydrogen
peroxide produced serve as a substrate for myeloperoxidase, an enzyme stored in
azeurophilic granules that is released into phagolysozomes or to the exterior o f the
cell. This enzyme catalyzes the conversion o f hydrogen peroxide to water with the
concomitant oxidation o f chloride ions to hypochlorus acid, a strong oxidizing agent
well known for its bactericidal action.
Until recently, hypochlorus acid was not believed to cause intracellular damage
because it is unable to cross membranes, however, recent studies (Test, Lampert,
Ossanna, Thoene, & Weiss, 1984) have shown that hypochlorus acid can react with
endogenous amines to form both hydrophilic and hydrophobic chloramines.
Intracellular damage can be caused by hydrophobic chloramines which are lipophillic,
longer lived, and able to cause damage by oxidation or chlorination o f a substrate
(Test et al., 1984). While many investigators believe that hypochlorus acid is the
oxidative product primarily responsible for neutrophil toxicity, other compounds such

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

9
as singlet oxygen (Kanosky, Wright, Miles-Richardson, & Tauber, 1984) and hydroxyl
radical (Repine et al., 1989) are also believed to play a role.
Singlet oxygen is formed from the interaction o f hydrogen peroxide and
hypochlorus acid (Kanosky et al., 1984).

Hydroxyl radical is a product o f the

interaction between hydrogen peroxide and either iron or copper ions, illustrated in the
Fenton or Haber-Weiss reactions (Bast, Haenen, & Doleman, 1991). While both are
highly reactive and destructive molecules, it is difficult to attribute tissue damage to
either, due to the difficulty o f detecting them in vivo.

Superoxide and hydrogen

peroxide have also been implicated as the primary injurious agents in inflammatory
damage, although superoxide tends to react with itself rather then other molecules
(Weiss, 1989). Both superoxide and hydrogen peroxide are rapidly inactivated by
large constitutive amounts o f superoxide dismutase and catalase (Bast, Haenen, &
Doleman, 1991).
Neutrophils also contain many hydrolytic enzymes that cause tissue damage.
These include elastase, collagenase, gelatinase, cathepsin G and others (Weiss, 1989).
The most destructive o f these enzymes is elastase. This enzyme can act upon many
molecules including elastic connective tissue, types III and IV collagen, plasma
proteins, complement factors, fibronectin and proteoglycans (Janoff, 1985). This is
especially injurious to the lung, which relies on elastic tissue for its compliance (Janoff,
1985).

Studies have shown that intratracheal instillation o f elastase causes

emphysema-like diseases in experimental animals (Senior et al., 1977). Since the lung
is the site o f a continuous barrage o f compounds capable o f eliciting an inflammatory
response, it is not surprising that the body is adept at preventing the accumulation o f
elastase. The major defense against elastase in the lung is a-1 proteinase inhibitor (alp i) which irreversibly binds to and inactivates elastase (Carrell, 1986). This protease

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

10
is found in equal concentrations in the extracellular matrix o f the lung and blood
plasma, and is the only significant protease activity in the normal lung (Gadek, Fells,
Zimmerman, Rennard, & Crystal, 1981). This is illustrated in the case o f persons with
congenital deficiencies in a -lp i.

These subjects exhibit a severe early onset

emphysema, a disease associated with the loss o f lung compliance by elastic tissue
destruction (Janoff, 1985). In inflammatory processes, edema provides an influx o f
plasma proteases that include a -lp i and a-2 macrogloubin, another protease effective
against elastase (Gadek et al., 1981).
Considering the abundance o f antiproteases available, it is surprising that
elastase can cause significant lung damage. This has been explained by the synergistic
interactions between hypochlorus acid and elastase. Release o f hypochlorus acid into
the extracellular matrix causes the oxidation and deactivation o f tissue a -lp i, which
allows elastase to operate freely in the extracellular space (Weiss, & Regiani, 1984).
Hypochlorus acid is also responsible for the activation o f collagenase (Weiss, Peppin,
Ortiz, Ragsdale, & Test, 1985) and gelatinase (Peppin, & Weiss, 1986).

These

enzymes are stored in granules and released as inactive proenzymes (Wiess, 1989).
Interaction with HCA causes cleavage o f the proenzymes to their active forms (Weiss,
1989). This was shown in subjects whose neutrophils do not produce hypochlorus
acid. These persons secrete normal amounts o f inactive enzymes from neutrophils, but
no active enzyme can be detected (Weiss et al., 1985).
Taken individually, these processes seem simple and well defined. In an in vivo
system this is not the case. Inflammation is provoked by a stimulus, which in the case
o f 1-NN could either be a direct reaction to the compound, its metabolites, or the
result o f toxic injury to the cells. Regardless o f the stimulus, once initiated, resident
cells such as mast cells, macrophages, and endothelial cells release cytokines and
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chemotactic molecules that cause increased vascular permeability, hypotension, and
expression o f leukocyte adhesion molecules on endothelial cells (Williams & Hellewell,
1992).

This results in the acute inflammatory response.

Whether or not acute

inflammation proceeds into chronic inflammation depends on the duration o f the
stimulus.
Purpose o f the Study
The purpose o f the following study was to determine i f inhibition o f
cytochrome P-450 or neutrophil depletion could attenuate pulmonary damage caused
by 1-NN. This was done using chloramphenicol, a suicide substrate for cytochrome P450 that has been shown to be effective in the lung in vivo (Naslund & Halpert, 1984)
and cyclophosphamide, a chemotherapeutic agent commonly used to deplete
granulocytes prior to bone marrow transplants.
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MATERIALS AND METHODS
Experimental Design
This study was divided into two parts. The first was an electron and light
microscopic evaluation o f rat lungs after various treatments.

The second was an

analysis o f biochemical indicators o f inflammation and cell damage in rats receiving
identical treatments to the first. This was performed by analysis o f bronchoalveolar
lavage (BAL) fluid and tissue homogenates.
Procedures
Animals and Treatments
Male CD rats (Charles River Labs, Portage, Michigan) weighing between 150250 grams were used in all experiments. Animals were housed according to University
guidelines, with rat chow #5001 (Purina Mills, St. Louis, MO) and tap water provided
ad libitum.
Table 1 shows the treatment received by each group and the number o f animals
used in morphological analysis, while Table 2 shows the number o f animals used for
bronchoalveolar lavage analysis. In all experiments, the start time, which corresponds
to 1-NN administration, is termed time 0. A ll drugs were administered as single i.p
injections. 1-NN was solubilized in a few drops o f diethyl ether, dissolved in food
grade peanut oil (Planters), and given as a 100 mg/kg dose at a concentration o f 50
mg/ml. Chloramphenicol was dissolved in propylene glycol and administered as a 100
mg/kg dose at minus 1 hour at a concentration o f 50 mg/ml. Cyclophosphamide was
12
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Table 1
Necropsy Schedule for Morphological Analysis
Number o f Animals
Treatment Time
Group

Treatment

+6 hour

+12 hour

1

1-NN

2

3

2

1-NN and
CPA

3

3

3

1-NN and
CPM

3

2

4

CPA only

3

3

5

CPM only

3

3

6

Untreated
Control

5

1-NN = 1-nitronaphthalene, CPA = chloramphenicol, CPM = cyclophosphamide
dissolved in distilled water and administered as a single 150 mg/kg dose at minus 72
hours at a concentration o f 30 mg/ml. Subjects were removed from food at time 0.
Lung Perfusions
At either plus 6 or plus 12 hours, the animals were sacrificed and their lungs
were perfused according to the following procedure: After a lethal injection o f 50
mg/kg sodium pentobarbital i.p, the trachea was exposed and cannulated with a 2 mm
diameter polyethylene tube connected to a small animal respirator. The lungs were
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Table 2
Necropsy Schedule for Bronchoalveolar Lavage Analysis

Number o f Animals per Group at +12 Hours
Group

1

2

3

4

5

6

7*

5

5

5

5

7*

*An n o f 3 was used in these groups for myeloperoxidase analysis.
inflated to 20 mm o f water pressure and the chest was opened to expose the thoracic
cavity. The aorta was cut to gather a blood sample using EDTA as an anticoagulant,
and the left ventricle o f the heart was slit to allow perfusate to escape. A 23 gauge
Minicath® (Deseret Medical, Sandy Utah) was inserted into the right ventricle and the
lungs were perfused with 10 ml o f saline containing 10 units o f ammonium heparin/ml.
This was followed by 20 ml o f 3% gluteraldehyde in 0.1 M cacodylic acid buffer,
which consisted o f 0.1M cacodylic acid, pH 7.4, with 10% sucrose. This formulation
was used in all electron microscope experiments. After perfusion with fixative, the left
lung and the inferior lobe o f the right lung were removed and immersed in fresh
fixative for forty five minutes. Subsequently, the left lung was sectioned into three
longitudinal slices and placed into aqueous 10% formalin overnight in preparation for
light microscopic analysis. The inferior lobe o f the right lung was sliced into several
0.5x3 mm pieces and processed for electron microscopic analysis.
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Microscopic Preparation
Electron Microscopy
After three washes in buffer, the samples were post-fixed in 1% osmium
tetroxide in 0.1M cacodylic acid buffer for one hour followed by three washes in
buffer. The tissue was dehydrated in a graded ethanol series, cleared in propylene
oxide, and embedded in Polybed 812 (Polysciences, Warrington, PA) in flat
embedment molds.

One-half micron sections were cut on a Sorvall M T 5000

ultramicrotome and stained with toluidine blue. The following criteria was used to
determine appropriate areas for electron microscopic examination: To be considered a
distal or terminal bronchiole, the cell population consisted o f Clara and ciliated cells
with no goblet or basal cells present. The epithelium was simple in nature, and the
basal lamina had irregular bundles o f smooth muscle and connective tissue.

This

procedure insured that local changes in airway diameter or alteration o f cell
morphology did not cause the wrong type o f airway to be subsequently examined.
Blocks containing distal or terminal bronchioles were trimmed and thin sectioned on a
Sorvall M T 5000 or LKB Nova ultramicrotome using glass knives and placed on 300
mesh copper or nickel grids. The samples were stained with 5% methanolic uranyl
acetate and Reynolds lead citrate and examined on a Siemens 101 Elmiskop at 80Kv.
Appropriate sections were photographed for later examination.
Light Microscopy
After fixing overnight in 10% formalin, the slices were dehydrated in a graded
ethanol series followed by clearance in xylene and embedment in paraffin (Tissue-Tek,
Fisher Scientific). The samples were cut on a Reichert-Jung Biocut 2030 microtome
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and stained with Gills hematoxylin and phloxine eosin. The slides were viewed and
photographed using a Nikon Microphot FXA and Kodak 160T film.
Bronchoalveolar Lavage
Lavage procedures were performed according to Roth (1981). Treatments
were identical to the ones employed in the morphological analysis except that 12 hours
was the only time point used. The number o f subjects for this experiment is presented
in Table 2. After a lethal injection o f 50 mg/kg o f sodium pentobarbital i.p., the
abdomen was opened and the renal arteries or abdominal aorta was cut to
exsanguinate the animal. In the case o f animals receiving cyclophosphamide blood
was collected over EDTA to confirm that leukocyte depletion had taken place.
Results indicated that these animals had a leukocyte count similar to that observed in
cyclophosphamide treated animals used for morphological analysis. The thorax was
gently compressed to expel the remaining blood from the heart-lung block and the
trachea was exposed and cannulated with a 2 mm diameter polyethylene tube. The
lungs were lavaged twice with 23ml/kg o f 0.9% saline using a glass syringe. The
recovered lavages were pooled and centrifuged at 900 xg for 10 minutes at 4°C. The
supernatants were drawn o ff and stored at -70° F for further analysis. The cells pellets
were resuspended in 0.9% saline and stored on ice for cells counts. Tissue samples
selected for measurement o f myeloperoxidase activity were excised and homogenized
with a glass homogenizer in 2 ml o f hexadecyltrimethylammonium bromide buffer
(HTBS, H-5882, Sigma Chemical Co), which consisted o f 0.5 grams o f HTBS in 100
ml o f 50 mM phosphate buffer, pH 6.0. After centrifugation at 20,000 xg for thirty
minutes at 4° C, the supernatants were drawn o ff and stored at -70° F for later
evaluation.
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Protein Analysis
Protein was measured using a Lowry assay (Lowry, Rosebrough, Farr, &
Randall, 1951). A 100)iL sample o f cell-free BAL fluid was added to 400pL o f water,
and 2 ml o f Lowry reagent D. This was vortexed, and 200pL o f IN phenol reagent
was added. After 30 minutes the Absorbance was measured at 550nm using a Biorad
microtiter plate reader. Bovine serum albumin (Sigma Chemical Co, St. Louis, MO)
was used to generate a standard curve.
Cell Counting Procedure
After the BAL supernatant was removed, the cell pellet was resuspended in an
identical amount o f 0.9% saline. Cells were counted in the four O .lpL counting
chambers o f an American Optical hemocytometer excluding red cells and fragments.
White blood cell counts were determined by the method described by Brown
(1984). A sample o f blood was collected using EDTA as an anticoagulant, drawn into
a white blood cell counting pipette, and diluted to the mark with 3.0% acetic acid.
After shaking for several minutes, roughly half o f the fluid was drained, and the rest
was placed into a hemocytometer and counted on the WBC counting squares o f an
American Optical Hemocytometer and expressed as cells/pL.

Lactate Dehydrogenase Assay
Lactate dehydrogenase activity was assayed using diagnostic assay kit DG1340k from The Sigma Chemical Company (St. Louis, MO), which measures the loss
o f NAD+ in a sample. Horseradish Peroxidase was used as a positive control, a
sample mixture made from boiled tissue was used as a negative control and the assay
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mixture was standardized with Sigma LIN-TROL. A ll samples were run at one time
to prevent any change in reagent activity. Change in Absorbance was measured with a
Gilford spectrophotometer and defined as units/liter.
Myeloperoxidase Assay
Measurement o f tissue myeloperoxidase activity was defined utilizing the
method o f Krawisz, Sharon, & Stenson, (1984). After homogenization with a glass
homogenizer in 2 ml o f HTBS buffer, and three freeze-thaws, the sample was
centrifuged at 20,000 x g for 30 minutes in a microfuge at 4°C. The supernatant was
removed and stored at -70° F. To determine myeloperoxidase activity, 50 |iL o f the
supernatant was added to 2.95 ml o f 0.169 mg/ml o-dianisidine dihydrochloride in
100ml o f 6.0 mM phosphate buffer, pH 6.0, containing 0.0005% hydrogen peroxide.
The sample and incubation mixture were shaken and the change in Absorbance was
read at 460 nm using a Gilford spectrophotometer over three minutes, and expressed
as units/milligram o f protein.
Statistical Analysis
Statistical analysis was used to determine if significant differences occurred
between the groups being examined. Data was run as two sets. The first consisted o f
the Chloramphenicol treated groups and was composed o f the 1-NN control,
chloramphenicol pretreated group, chloramphenicol control, and untreated control
The second data set was composed o f groups treated with cyclophosphamide and
contained the 1-NN control, cyclophosphamide pretreated group, cyclophosphamide
control, and untreated control.

An analysis o f variance was first done using the

program supplied with Microsoft Excel®. A g o f 0.05 was used to determine if a

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

19
significant difference existed across the set. I f this occurred, the components were
examined using the Newman-Keuls test o f multiple comparisons w ith g<0.05.
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RESULTS
General Observations
l-Nitronaphthalene has been shown to produce a pronounced respiratoiy
distress in rodents (Johnson, et al., 1984). This observation held true beginning as
early as 1 hour after 1-NN treatment, where exaggerated chest movements were
displayed.

Six hours after 1-NN treatment, the symptoms included a wet, raspy

breathing.

These animals were very lethargic, and displayed none o f the evasive

responses to being handled that control animals did. By +12 hours the symptoms
included pronounced gasping and signs o f a fluid discharge around the nostrils. A t no
time did the animals show significant signs o f hypoxia, such as cyanosis o f the mucus
membranes, and no animals died due to drug treatments.
Morphological Evaluation
Untreated Control Rats
Terminal airway epithelium from untreated controls displayed morphology that
was consistent with observations described by Breeze & Wheeldon (1977), as seen in
Figure 1. The Clara cells appeared as columnar cells with rounded apical surfaces that
were centrally located, oval in shape and indented. The chromatin was fine and evenly
dispersed throughout the nucleus. Small mitochondria were scattered throughout the
cytoplasm along with electron dense granules that were located primarily in the apical
region o f the cell. The Clara cells also contained an abundant amount o f agranular and
granular endoplasmic reticulum as compared with other epithelial cells.
20
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The surrounding ciliated cells appeared to have normal morphology as
described by Breeze & Wheeldon (1977).

The cells had a cuboidal appearance

roughly half the size o f the columnar Clara cells.

The ciliated epithelium had an

overall electron-dense cytoplasm, although small mitochondria and endoplasmic
reticulum could be seen throughout.

The nuclei were centrally located with fine,

evenly dispersed chromatin. Abundant cilia was present and attached at apical basal
bodies. Lateral tight junctions between the Clara cells and ciliated cells were readily
observable. The basal lamina consisted o f tightly packed bundles o f collagen and
irregular bundles o f smooth muscle and elastic connective tissue.
Toluidine blue sections showed a simple epithelium with columnar Clara and
cuboidal ciliated cells present, as seen in Figure 2. This epithelium was attached to the
basement membrane, and there did not appear to be any debris in the airway. Blood
vessels proximal to the airway did not show an edematous region around the vessel or
an apparent efflux o f cells, and the alveolar air spaces had a normal appearance.
1-Nitronaphthalene Treated Rats
In all o f the following groups, most characteristics evaluated displayed minimal
changes between animals examined at +6 hours compared to +12 hours.

When

significant differences are noted they w ill be followed by a notation o f the time.
There was a marked difference between morphological profiles o f untreated
controls and 1-NN treated animals as seen in Figure 3. Electron micrographs showed
patchy sloughing o f epithelial cells from the majority o f the distal airways.

The

sloughed cells that were still present in the airways consisted o f single cells that were
usually Clara cells, or groups o f 2-5 cells that were combinations o f Clara and ciliated
cells joined at lateral tight junctions. Cells that were free in the airways tended to
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Figure 1.

Electron Micrograph o f Distal Airway Epithelium From an Untreated
Rat.
In this micrograph, observe the columnar Clara (CA) cells and cuboidal
ciliated cells (CL) attached to the basement membrane (BM). Also,
notice the fine chromatin in the nuclei (N), the well defined
mitochondria (M ) and endoplasmic reticulum (ER). The bar is 1
micron.
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Figure 2.

Photomicrograph o f Distal Airway Epithelium From an Untreated Rat.
In this micrograph, observe the Clara (CA) and ciliated cells (CL) on
the basement membrane. Also observe the alveolar air spaces (A), and
proximal blood vessel (V) with no swelling or fluid accumulation
visible.
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retain the integrity o f their plasma membranes evaluated by the absence o f cytoplasmic
components outside the cell. The most prominent feature o f the adherent epithelium
was that the once columnar Clara cells now had a low cuboidal shape. These cells
showed hydropic changes in the form o f dilation o f the endoplasmic reticulum
indicated by the presence o f hydropic vacuoles and vesicles. The average Clara cell
had an occasional hydropic vacuole, with many more vesicles seen throughout the cell.
Many o f the mitochondria were enlarged. There was a reduction in the number o f
granules present compared to untreated controls. The nuclei displayed clumping o f
chromatin along the periphery o f the nuclear membrane six hours after 1-NN
treatment, and by twelve hours many o f the cells had a dilated nuclear membrane.
The ciliated cells also presented an altered profile six hours after treatment with
1-NN; which increased in severity after twelve hours. The cells showed hydropic
changes in the form o f vacuoles, but this was not as severe as the adjacent Clara cells.
A t both time points, many ciliated cells had a loss o f cilia with only the basal bodies
remaining.

A number o f ciliated cells were also sloughed from the basement

membrane. While some o f these cells were free, the majority were attached to Clara
cells at lateral tight junctions.
The basal lamina exhibited an expanded appearance compared to untreated
controls. There was an accumulation o f fluid in the interstitum, as evidenced by the
separation o f the collagen bundles. There was also an increase in the cellularity o f the
interstitum that did not seem to increase significantly between +6 and +12 hours.
Electron micrographs showed these cells to be neutrophilic and agranular leukocytes.
Toluidine blue sections showed airways containing a patchy sloughing o f
epithelial cells. The cells appeared highly vacuolated and free cells were present in the
lumen. Epithelial damage was present in all bronchioles observed regardless o f size or
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cell type present, as seen in Figure 4. The basal lamina had an accumulation o f fluid,
and blood vessels proximal to the airways were also edematous with a cellular
accumulation around them.

The air spaces were enlarged compared to untreated

controls.
Chloramphenicol With 1-NN Treated Rats

Animals treated with 100 mg/kg chloramphenicol one hour prior to treatment
with lOOmg/kg 1-NN i.p. showed a reduction in intracellular damage compared to
animals treated with 1-NN only, as seen in Figure 5. The most prominent feature was
that the Clara cells retained their columnar shape. The cells were adherent to the
basement membrane and there was no change in the morphology o f the ciliated cells.
Some cells displayed a hydropic profile consisting o f a slight accumulation o f vacuoles
and vesicles in the cytoplasm. While this feature was not common, it was not present
in the untreated controls nor animals treated with chloramphenicol only, and was
therefore attributed to be an effect o f 1-NN. The basal lamina displayed an interstitial
fluid accumulation in half o f the micrographs, but was not as prominent as in animals
treated with 1-NN only.
Toluidine blue sections showed bronchioles that appeared similar to untreated
controls with the Clara cells retaining their columnar appearance, as seen in Figure 6.
Tissue surrounding blood vessels proximal to the airways displayed an interstitial
edema that closely resembled animals treated with 1-NN. A similar accumulation o f
neutrophils and lymphocytes was present in the interstitum. The alveolar air spaces
were enlarged as compared with untreated controls. A t +12 hours many o f the blood
vessels were surrounded with an opaque exudate in contrast to the clear transudate
seen in the six hour samples.
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Figure 3.

Electron Micrograph o f Distal Airway Epithelium From a Rat 12 Hours
After Treatment W ith 1-Nitronaphthalene.
In this figure, note the Clara cells (CA) sloughing from the basement
membrane (BM). The cells have condensed chromatin in the nucleus
(N) and hydropic vacuole formation (V). The ciliated cells (CL) show
less extensive damage, although in some cases, only the basal bodies
(arrowheads) o f the cilia are visible. Also, note the fluid accumulation
in the interstitial space (F). An artifact (A) is also present in this
micrograph. The bar is 1 micron.
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Figure 4.

Photomicrograph o f Distal Airway Epithelium From a Rat 12 Hours
After Treatment With 1-Nitronaphthalene.
In this micrograph, observe the flattened appearance o f the airway
epithelium, and the perivascular edema (E) with cellular infiltration
(arrowheads). Swelling o f the alveolar air spaces is also visible (A).
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Chloramphenicol Control Rats
Animals treated with lOOmg/kg chloramphenicol showed no changes as
compared with untreated controls except for the following: There appeared to be a
prominent blebbing from the apical portion o f many Clara cells, as seen in Figure 7.
The bleb consisted o f a cytoplasmic outpouching filled with a fine electron dense
material. There were no characteristic Clara cell granules present in the blebs. This
morphology was not present in animals pretreated with chloramphenicol prior to 1-NN
or untreated controls. The material present in the blebs was described by Breeze &
Wheeldon (1977) as disintegrating smooth endoplasmic reticulum.
Ciliated cells showed no changes in morphology as compared with untreated
controls.
Toluidine blue sections showed the normally round apical surfaces o f many o f
the Clara cells appearing as irregularly shaped, elongated protrusions as seen in Figure
8. Tissue surrounding blood vessels proximal to the distal bronchioles showed little to
no edema or neutrophil emigration. The alveolar air spaces did not show enlargement
compared to untreated controls.
Cyclophosphamide With 1-NN Treated Rats
Except

for

the

following

nuclear

changes,

animals

treated

with

cyclophosphamide and 1-NN did not show any significant changes compared to
animals treated with 1-NN only, as seen in Figure 9. Many Clara cells displayed a
cuboidal appearance in contrast to the columnar shape seen in untreated controls.
Epithelial sloughing was present and involved both ciliated and Clara cells. The nuclei
were pyknotic with chromatin that was much more electron dense than at
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Figure 5.

Electron Micrograph o f Distal Airway Epithelium From a Rat 12 Hours
After 1-Nitronaphthalene Treatment With Chloramphenicol
Pretreatment.
In this figure, note the columnar appearance o f the Clara cells (CA) and
the well defined endoplasmic reticulum (ER). There is a lack o f
toxicity in the Clara cells and ciliated cells (CL) compared to 1-NN
controls in Figure 3. Note that all o f the cells are attached to the
basement membrane (BM). Also, note cellular accumulation in the
interstitum (arrowheads). The bar is one micron.
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Figure 6.

Photomicrograph o f Distal Airway Epithelium From a Rat 12 Hours
After 1-Nitronaphthalene Treatment With Chloramphenicol
Pretreatment.
In this micrograph, observe the airway epithelium which closely
resembles the untreated control. Also, observe the perivascular edema
(E), cellular infiltration (I) and enlargement o f the alveolar air spaces
(A).
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Figure 7.

-

■

Electron Micrograph o f Distal Airway Epithelium From a Rat Treated
With Chloramphenicol.
In this micrograph, notice the Clara (CA) and ciliated (CL) cells do not
show a morphological difference compared to untreated controls.
These cells have well defined granules (G), endoplasmic reticulum (ER)
and nuclei (N). A ll o f the cells are attached to the basement membrane
(BM). Also, note the bleb (B) from the Clara cell which was specific to
this group. The bar is one micron.
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Figure 8.

Photomicrograph o f Distal Airway Epithelium From a Rat
Treated W ith Chloramphenicol.
In this micrograph, observe the airway epithelium, which resembles the
untreated control. Also, observe the lack o f perivascular edema, cell
infiltration and alveolar enlargement compared to the group pretreated
with chloramphenicol prior to 1-NN.
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corresponding time points in animals treated with 1-NN only. Many o f the nuclei were
accumulating fluid and some were beginning to show early signs o f kaiyorrhexis.
Many Clara cells had dilated nuclear membranes. Mitochondria were swollen and
there was a loss o f granule contents.

Hydropic vacuole and vesicle formation

observed was consistent with 1-NN treated animals.
Ciliated cells showed damage similar to that seen in animals treated with 1-NN
only. There was a loss o f cilia, and the cells in the twelve hour groups showed slight
hydropic changes.

Many o f the ciliated cells were sloughed from the basement

membrane; although most o f these cells were still attached to Clara cells at lateral tight
junctions.
Toluidine blue sections showed a morphology similar to 1-NN controls as seen
in Figure 10. The Clara cells were flattened and sloughed from the basement
membrane.

Blood vessels proximal to the airways showed edema with an

accumulation o f cells in the interstitum.
Cyclophosphamide Control Rats
There were no significant morphological changes observed between
Cyclophosphamide controls and untreated control rats at the electron level, as seen in
Figure 11.
Toluidine blue sections showed normal airway epithelium, as seen in Figure 12.
The tissue surrounding the blood vessels displayed no edema, and the alveolar air
spaces did not appear enlarged compared to untreated controls.
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Figure 9.

Electron Micrograph o f Distal Airway Epithelium From a Rat 6 Hours
After 1-Nitronaphthalene Treatment With Cyclophosphamide
Pretreatment.
In this micrograph, notice the Clara (CA) and ciliated (CL) cells
sloughed from the basement membrane (BM) and the are o f proteincontaining fluid (P) between the two. Note the hydropic vacuole (V )
formation, and the fluid accumulation in the nuclei (N). There was also
an accumulation o f fluid (F) in the interstitum. The bar is 1 micron.
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Figure 10.

Photomicrograph o f Distal Airway Epithelium From a Rat 12 Hours
After 1-Nitronaphthalene Treatment With Cyclophosphamide
Pretreatment.
In this micrograph, observe the sloughed airway epithelium (E),
perivascular edema (D), cell infiltration (C), and alveolar enlargement
(A).
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life

Figure 11.

Electron Micrograph o f Distal Airway Epithelium From a Rat Treated
With Cyclophosphamide.
In this figure, note the appearance o f the Clara (CA) and ciliated (CL)
cells, which closely resemble the untreated controls. The cells have
well defined endoplasmic reticulum (ER), electron dense granules (G),
and are attached to the basement membrane (BM). Also, note the fine,
evenly distributed chromatin in the nuclei (N). The bar is one micron.
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Figure 12.

Photomicrograph o f Distal Airway Epithelium From a Rat
Treated With Cyclophosphamide.
In this micrograph, observe the close appearance o f the airway
epithelium to the untreated control. There is no perivascular edema,
alveolar enlargement or cellular infiltration.
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Biochemical Analysis
Cell Counts
In Figures 13-20, bars represent the average value for the parameter being
examined, while error bars represent the standard deviation.
An influx o f cells into BAL fluid is indicative o f an inflammatory response.
Figure

13 shows the average total cell counts for animals treated with

chloramphenicol. There was a significant increase in cells found in BAL fluid between
the 1-NN control and the chloramphenicol pretreated groups compared to the
untreated control. There was also a significant increase between the chloramphenicol
pretreated group and the chloramphenicol control.

A differential analysis o f cells

recovered from BAL fluid did not produce conclusive results due to poor readability
o f the slides.
Figure 14 shows the average cell counts for groups treated with
cyclophosphamide. There was a significant increase between the 1-NN control and
the cyclophosphamide pretreated groups compared to the untreated control.
Table 3 shows the leukocyte counts from all groups. There was a significant
decrease between animals treated with cyclophosphamide and the untreated control,
regardless o f treatment with 1-NN. Table 4 shows the differential white blood counts
from all groups. This is presented as % neutrophils and % lymphocytes. Since the
combination o f eosinophils, basophils and monocytes totaled less then 6% o f the total
differential count, their numbers are not presented. There was a significant decrease in
neutrophil content between groups treated with cyclophosphamide compared to the
untreated control, regardless o f treatment with 1-NN.
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Figure 13.

Average Cell Count From BAL Fluid o f Chloramphenicol
Pretreated Rats.
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Protein Analysis
An accumulation o f protein in BAL fluid is another indicator o f inflammation.
Figure 15 shows the average protein content from BAL fluid o f animals treated with
chloramphenicol.

There was a significant increase between 1-NN controls and

chloramphenicol pretreated groups compared to the untreated control. There was also
a significant difference between the chloramphenicol pretreated group and the
chloramphenicol control.
Figure 16 shows the protein content o f BAL fluid from animals receiving
cyclophosphamide. There was not a significant increase between any o f the groups.
Myeloperoxidase Analysis
Myeloperoxidase is an enzyme secreted from neutrophils and macrophages in
response to inflammatory stimuli. Tissue myeloperoxidase activity was measured to
determine whether there was an efflux o f neutrophils from the vasculature into the
extracellular space.

Figure 17 shows the average tissue myeloperoxidase activity

from animals treated with chloramphenicol.

There was a significant increase in

myeloperoxidase activity in 1-NN controls and chloramphenicol pretreated groups
compared to the untreated control. There was also a significant increase between the
chloramphenicol pretreated group compared to the chloramphenicol control.
Figure 18 shows the average tissue myeloperoxidase activity from animals
treated with cyclophosphamide. There was a significant difference between the 1-NN
control and the untreated control. There was also a significant difference between the
1-NN control and the cyclophosphamide pretreated group.
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Figure 14.

Average Cell Count From BAL Fluid o f Cyclophosphamide Pretreated
Rats.
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Table 3
Average White Blood Cell Counts
White Count*
Treatment Time
Group

Treatment

+6 Hours

+12 Hours

1

1-NN

4,767 +/- 2,702

4,791 +/- 2,790

2

1-NN and
CPA

5,125 +/- 1,530

5,443 +/- 1,366

3

1-NN and
CPM

1,187+/-300

1,050 +/- 247

4

CPA

9,641 +/- 1,661

6,833 +/- 1,502

5

CPM

625 +/- 163

791 +/- 76

6

Untreated
Control

7,865 +/- 2,061

7,865 +/- 2,061

* Represented as cells/pL +/- standard deviation.
CPA = chloramphenicol, CPM = cyclophosphamide
Lactate Dehydrogenase Analysis
Lactate Dehydrogenase is an intracellular enzyme that is commonly used as a
marker o f cellular damage or membrane leakiness. The average lactate dehydrogenase
activity from BAL fluid in groups treated with chloramphenicol is seen in Figure 19
while the average lactate

dehydrogenase activity in

groups

treated with

cyclophosphamide is seen in Figure 20. There was not a significant change between
any o f the groups.
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Figure 15.

Average Protein Content o f BAL Fluid From Chloramphenicol
Pretreated Rats.
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Figure 16.

Average Protein Content From BAL Fluid From Cyclophosphamide
Pretreated Rats.
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mpo

1

1-NN* 1-NN+CPA*'

CPA

UT

Group

Leeend.

* Significant difference compared to untreated control.
' Significant difference compared to treated control.
UT = untreated control, CPA = chloramphenicol
MPO = myeloperoxidase

Figure 17.

Average Tissue Myeloperoxidase Activity From Chloramphenicol
Pretreated Rats.
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- ■

1-NN* 1-NN+CFM* CPM

UT

Group

Legend.

* Significant difference compared to untreated control.
" Significant difference compared to 1-NN control.
UT = untreated control, CPM = cyclophosphamide
MPO = myeloperoxidase

Figure 18.

Average Tissue Myeloperoxidase Activity From Cyclophosphamide
Pretreated Rats.
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Table 4
Average Differential White Blood Cell Counts
% o f Cells*
Treatment Time
Group

+12 Hours

+6 Hours

%Neutro

%Lymph

%Neutro

%Lymph

1

27

70

30 +/- 2

66 +/- 1

2

33 +/-12

64 +/-12

34 +/- 7

63 +/- 9

3

6 +/- 0.7

88+/-0.1

1+1-2

88 +/- 2

4

49 +/- 8

46 +/- 8

47 +/- 14

48+/- 15

5

5+1-2

88 +/- 1

5 + /- 1

89 +/- 0.9

6

27 +/- 7

70 +/- 7

27 +/- 7

70+ /-7

♦Represented as average % o f this cell type +/- the standard deviation.
Neutro = Neutrophil, Lymph = Lymphocyte
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L fcH U /L

1-NN

1-NN+CPA

CPA

UT

G roup

Legend.

UT = untreated control, CPA = chloramphenicol
LDH = lactate dehydrogenase

Figure 19.

Average Lactate Dehydrogenase Activity From BAL Fluid o f
Chloramphenicol Pretreated Rats.
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ld h

1-NN

1-NN+CPM

CPM

UT

Group

Legend.

UT = untreated control, CPM = cyclophosphamide
LDH = lactate dehydrogenase

Figure 20.

Average Lactate Dehydrogenase Activity From BAL Fluid o f
Cyclophosphamide Pretreated Rats.
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DISCUSSION
The purpose o f this study was to determine i f inhibition o f cytochrome P-450
or neutrophil depletion could modulate the pneumotoxicity caused by 1-NN.
Assuming that 1-NN metabolites are cytotoxic, inhibition o f their production would be
expected to decrease the extent o f intracellular damage associated with 1-NN toxicity;
while depletion o f neutrophils would remove the majority o f cytotoxic products o f
inflammatory cell infiltration.
When drugs are used to assess the mechanism o f action o f a toxic compound,
several criteria must be met. The drug should be specific for the process that is to be
examined, and relatively non-toxic. I f the drug has unwanted effects, they should not
interfere with the scope o f the investigation. It is preferable to know the mechanism o f
action so that the possibility o f cross-reactivity can be eliminated. In the case o f
chloramphenicol, these criteria are met fairly well. This compound covalently binds in
the active site o f several cytochrome P-450 isozymes (Halpert, 1981) with no evidence
o f cross-reactivity with other enzymes or the heme moiety o f P-450.

This is an

important consideration, since heme is present in many enzymes, and reactions with it
can interfere with other systems. While chloramphenicol does cause blood dyscrasias,
such as neutropenia and thrombocytopenia in a clinical setting, this is not likely to be a
factor in an acute experiment.
Chloramphenicol functions as an anti-bacterial agent by inhibiting protein
synthesis, which could pose questions regarding the turnover o f P-450 and other
enzymes. Chloramphenicol was shown to distinguish between isozymes o f P-450 by
the use o f specific inducing agents (Halpert et a!., 1985), which indicates that the initial
50
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inhibitory action o f this compound is selective, and not due to inhibition o f de novo
protein synthesis. Also, the normal half-life for P-450 I£B1 is 19 hours (Gasser, Hauri,
& Meyer, 1982), which indicates that unless there is specific induction o f the isozyme,
less then 50% o f the existing P-450 would be replaced by the 12 hour time point used
in this experiment.
The previously mentioned criteria does not apply well to cyclophosphamide.
The task o f granulocyte depletion is not an easy one. There are two ways in which
granulocytes can be depleted. The first is physical depletion o f the cells, which is
commonly done using cytotoxic agents that prevent the division o f granulocytic
precursors in the bone marrow.

Cyclophosphamide along with many other

chemotherapeutic agents fall into this category. The primary fault o f these compounds
is their toxicity, which in many cases is directed towards the lung. The second type o f
depletion is functional, where there is no physical removal o f cells, but some aspect o f
their function is altered.

Included in this group is an enormous variety o f drugs

including antimetabolites, steroidal anti-inflammatories and antibodies to endothelial
adhesion molecules. The latter tends to be cost prohibitive, while the former tend to
either be toxic or have a myriad o f effects that would complicate a study.
Cyclophosphamide was chosen for several reasons:

While it is toxic,

cyclophosphamide has been thoroughly investigated (Moore, 1991) and is currently
used in clinical settings to deplete granulocytes prior to bone marrow transplants. The
toxic effects, which include lung fibrosis (Gould & Miller, 1975) have been determined
and the time course for their pathogenesis is well known and is outside o f the range o f
this experiment (Gould & Miller, 1975).

Cyclophosphamide is known to be

metabolized by PHS enzymes in murine lungs (Smith & Keherer, 1991) and its efficacy
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is not affected by inducing agents (Jao, Jusko, & Cohen, 1972). This indicates that
while cyclophosphamide is not an ideal drug, it is acceptable for this experiment.
Chloramphenicol was administered prior to treatment with 1-NN to determine
if inhibition o f P-450 would affect lung toxicity. Both light and electron microscopic
evidence clearly shows that cellular damage caused by 1-NN is greatly reduced after
pretreatment with chloramphenicol.

Sloughing o f bronchiolar epithelium was not

observed, and the Clara cells retained their columnar shape; which was not seen in
groups treated with 1-NN alone. However, chloramphenicol pretreatment did not
prevent the inflammatory response associated with 1-NN. This was observed in light
and electron micrographs, where fluid accumulation and inflammatory cell emigration
was evident. Consistent with 1-NN controls, alveolar air spaces were enlarged, and all
animals displayed signs o f respiratory distress regardless o f chloramphenicol
pretreatment.
Biochemical results agreed with morphologic findings regarding the
inflammatory response observed in chloramphenicol pretreated groups. In animals
receiving 1-NN with or without chloramphenicol pretreatment, there was a significant
increase in tissue myeloperoxidase activity, and a significant increase in protein and
cell content o f BAL fluid compared to untreated controls. There was also a significant
increase between cell counts, protein content and tissue myeloperoxidase activity in
groups receiving chloramphenicol prior to 1-NN compared to chloramphenicol
controls. There was no difference in these parameters between untreated controls and
chloramphenicol controls.

This indicates that the inflammatory response was not

caused by chloramphenicol treatment and was due to 1-NN.
Since the initial signal for the inflammatory response associated with a 1-NN
induced lesion is unknown, it is difficult to speculate on why inflammation is present in
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chloramphenicol pretreated animals. The most practical theory is that 1-NN does not
arrive in the lungs totally unchanged. Since a material injected i.p. makes contact with
peritoneal macrophages and the liver, both o f which contain P-450 isozymes, it is
likely that some 1-NN is metabolized prior to the involvement o f Clara cells. The
pulmonary endothelium also contains P-450 isozymes and is capable o f stimulating an
inflammatory response. A second theory is that some aspect o f pulmonary P-450
function, either uninhibited IIB1 or another isozyme that is not affected by
chloramphenicol, activates a basal amount o f 1-NN that is sufficient to stimulate an
inflammatory response without causing overt morphological changes.
Aside from an apparent increase in nuclear degeneration, animals pretreated
with cyclophosphamide prior to 1-NN did not display observable morphological
differences compared to 1-NN controls at either the light or electron level.
Intracellular changes included hydropic vacuole formation, mitochondrial swelling and
granule loss; while extracellular changes included edema, cellular infiltration and
epithelial sloughing. In many cases, there appeared to be greater nuclear damage in
animals receiving cyclophosphamide prior to 1-NN than with 1-NN alone.

These

changes consisted o f pyknosis, with the chromatin exhibiting a very electron dense
appearance, and fluid accumulation in many o f the nuclei.

There were no

morphological differences between the nuclei o f cyclophosphamide controls and
untreated controls. There is no explanation for this result in the literature reviewed,
but one possibility might be that since cyclophosphamide alkylates DNA, pretreatment
prior to 1-NN may cause an increase in the precipitation o f chromatin. Epithelial
sloughing and loss o f columnar shape were also visible in cyclophosphamide pretreated
groups. Neutrophils could be involved in epithelial sloughing due to direct attack o f
the basement membrane by oxidative or enzymatic products. Since cyclophosphamide
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pretreated groups displayed an 85% decrease in circulating lymphocytes and no
significant change in tissue myeloperoxidase activity, this does not seem likely.
Biochemical analysis did not necessarily support the micrographic evidence
regarding the inflammatory response. While there was a significant increase in cell
content o f the BAL fluid, there was not a significant increase in either tissue
myeloperoxidase activity or BAL protein content in animals pretreated with
cyclophosphamide prior to 1-NN. Both protein content and myeloperoxidase activity
can be readily explained. Myeloperoxidase is a marker o f neutrophil emigration, and
protein accumulation in tissue during inflammation has been shown to be a neutrophildependent process (Wedmere & Williams, 1981). Considering the 82% decrease in
blood neutrophil content, it is not surprising that these parameters did not increase.
The increase in BAL cell content in cyclophosphamide pretreated groups was
unexpected. A differential analysis o f these cells was attempted, but the results were
inconclusive. One possibility was that the increase could be due to division o f alveolar
macrophages and a decrease in macrophage adhesion due the increase in chemotactic
stimuli.

Another could be migration o f lymphocytes from bronchus associated

lymphoid tissue into the airways.
Morphological evidence can be used to explain the continued presence o f the
inflammatory response. Both electron and light micrographs show that the lungs from
cyclophosphamide pretreated animals contained mast cells and macrophages. Since
these cells are capable o f stimulating the primary inflammatory response (Metcalfe,
Costa, & Burd, 1992; Adams & Hamilton, 1992) this could explain why
cyclophosphamide had no apparent effect on inflammation. Another possibility lies in
the pulmonary endothelium.

There was no morphological evidence that

cyclophosphamide damaged these cells, which are capable o f stimulating an
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inflammatory response.

The morphological and biochemical results show that

cyclophosphamide pretreatment does not prevent pulmonary cytotoxicity or an
inflammatory response despite an 82% reduction in circulating leukocytes.
Surprisingly, there was not a significant increase in lactate dehydrogenase
activity in any o f the groups regardless o f treatment. An accumulation o f lactate
dehydrogenase is indicative o f cell lysis or an increase in membrane permeability.
Considering the extent o f epithelial damage observed, a significant increase in lactate
dehydrogenase activity was expected.
electron micrographs.

The explanation for this was found in the

While these pictures give little indication o f membrane

permeability, they do show that few if any o f the cells have lost the integrity o f their
plasma membranes, evaluated by the absence o f intracellular components in the
airways. Also, the hydropic changes observed in these cells do not seem as severe
compared to other studies which used agents that are known to attack membranes,
such as carbon tetrachloride, which show severe hydropic changes.
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CONCLUSION
The results presented in this study have shown that inhibition o f P-450
isozymes by chloramphenicol decreases the pneumotoxicity associated with 1-NN
exposure. However, chloramphenicol pretreatment did not prevent the inflammatory
response associated with 1-NN exposure evaluated by significant increases in tissue
myeloperoxidase activity, and BAL protein and cell content. While the stimulus for
the inflammatory response is not known, it seems likely that an alternate pathway
produces 1-NN metabolites in an amount that is sufficient to signal an inflammatory
response without causing significant morphological changes.
Depletion o f neutrophils with cyclophosphamide prior to 1-NN treatment did
not prevent the cytotoxicity or inflammatory response associated with 1-NN. This
indicates that intracellular damage is not due to involvement with reactive oxygen or
enzymatic products from neutrophils, and that the primary inflammatory response,
which is characterized by increased vascular permeability, is neutrophil-independent.
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